GlassScriptPhysician profile
Kim R Denton
NPI 1942250246
$1,118.27
in general payments reported to CMS, 2019-2025
18 companies · $177 in 2025
The $177 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.65 · 2021: $157 · 2022: $64.51 · 2023: $252 · 2024: $384 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $713 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $713.42 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $213.81 | 2023-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $167.96 | 2021-2023 | Orilissa, Lo Loestrin Fe |
| Abbott Laboratories | $149.16 | 2024 | Axium |
| Biogen, INC. | $111.70 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $97.93 | 2023-2025 | Myfembree |
| Pfizer INC. | $63.59 | 2019-2025 | |
| Daiichi Sankyo INC. | $57.77 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.57 | 2019-2023 | |
| Organon LLC | $38.63 | 2024-2025 | Jada System |
| Therapeuticsmd, INC. | $35.72 | 2019 | |
| Hologic Sales and Service, LLC | $29.57 | 2025 | Myosure Tissue Removal Device, Acessa Provu System, Novasure |
| Takeda Pharmaceuticals U.S.A., INC. | $19.93 | 2021 | |
| Channel Medsystems, INC. | $18.86 | 2024 | |
| Lilly USA, LLC | $17.09 | 2025 | Zepbound |
| Myovant Sciences INC. | $16.35 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $15.42 | 2025 | Prevena |
| Smith+Nephew, INC. | $12.83 | 2023 | Pico 7 |
| Davol INC. | $12.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kim Denton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.